Rentschler Biopharma SE, a contract development and manufacturing organization (CDMO) for biopharmaceuticals, has appointed Grace Kim as vice president business development – North America and APAC. This is a newly created, U.S.-based position.
 
“We are delighted to have Grace join Rentschler Biopharma,” said Federico Pollano, senior vice president business development, Rentschler Biopharma. “She is a talented leader with proven experience in successfully growing global CDMO businesses who shares our client-centric approach. Grace will play a key role in expanding our offering of best-in-class services for cell culture projects as well as for new therapeutic modalities. We warmly welcome Grace to our growing U.S.-based team.”
 
Ms. Kim is a business development executive with over 20 years of broad-based experience in the biopharmaceutical industry. She has a track record of driving growth in revenue through successful execution of long-term partnerships. Grace has held several global business development positions at companies specializing in process development and cGMP production of recombinant protein therapeutics in both microbial and mammalian expression systems. Most recently, she was vice president at Northway Biotechpharma. Before that, she held a senior leadership position with the global contract manufacturing organization, Samsung Biologics.